hypericin

hypericin is a lipid of Polyketides (PK) class. Hypericin is associated with abnormalities such as Dermatitis, Phototoxic, Dehydration, Photosensitization, Morphologically altered structure and Myocardial Infarction. The involved functions are known as Cell Cycle Checkpoints, Apoptosis, Acetylation, Cell Survival and Caspase Activation. Hypericin often locates in insoluble fraction, Cytoplasmic matrix, Protoplasm, Tissue membrane and Cytoplasm. The associated genes with hypericin are CDC37 gene, HSPA8 gene, RAF1 gene, cyclin H and FK228. The related lipids are Phosphatidylserines.

Cross Reference

Introduction

To understand associated biological information of hypericin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with hypericin?

hypericin is suspected in Dermatitis, Phototoxic, Photosensitization, Pneumonia, Psoriasis, Phototoxicity, Chronic infectious disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with hypericin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uterine Cervical Neoplasms D002583 10 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Neoplasms, Radiation-Induced D009381 3 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Burns D002056 34 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Per page 10 20 50 | Total 38

PubChem Associated disorders and diseases

What pathways are associated with hypericin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with hypericin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with hypericin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with hypericin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with hypericin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with hypericin?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with hypericin

Download all related citations
Per page 10 20 50 100 | Total 1000
Authors Title Published Journal PubMed Link
Van Kets V et al. Laser light activation of a second-generation photosensitiser and its use as a potential photomodulatory agent in skin rejuvenation. 2013 Lasers Med Sci pmid:22581390
Rainha N et al. Content of hypericins from plants and in vitro shoots of Hypericum undulatum Schousb. ex Willd. 2013 Nat. Prod. Res. pmid:22617156
Barrette K et al. Pattern of sensitivity of progressive cutaneous squamous cell carcinoma cells to UVB and oxidative stress-induced cell death. 2013 Photochem. Photobiol. Sci. pmid:22722579
Li J et al. Sequential systemic administrations of combretastatin A4 Phosphate and radioiodinated hypericin exert synergistic targeted theranostic effects with prolonged survival on SCID mice carrying bifocal tumor xenografts. 2013 Theranostics pmid:23423247
Kong M et al. Necrosis affinity evaluation of 131I-hypericin in a rat model of induced necrosis. 2013 J Drug Target pmid:23627568
Zhang W et al. Investigation of water-soluble inclusion complex of hypericin with β-cyclodextrin polymer. 2013 Carbohydr Polym pmid:23618281
Ocak Z et al. Effect of hypericin on the ADAMTS-9 and ADAMTS-8 gene expression in MCF7 breast cancer cells. 2013 Eur Rev Med Pharmacol Sci pmid:23690187
Strejčková A et al. Spatial orientation and electric-field-driven transport of hypericin inside of bilayer lipid membranes. 2013 J Phys Chem B pmid:23286583
Klejdus B et al. PAL inhibitor evokes different responses in two Hypericum species. 2013 Plant Physiol. Biochem. pmid:23254282
Galeotti N and Ghelardini C Reversal of NO-induced nociceptive hypersensitivity by St. John's wort and hypericin: NF-κB, CREB and STAT1 as molecular targets. 2013 Psychopharmacology (Berl.) pmid:23254377
Penjweini R et al. Modifying excitation light dose of novel photosensitizer PVP-Hypericin for photodynamic diagnosis and therapy. 2013 J. Photochem. Photobiol. B, Biol. pmid:23375215
Larisch P et al. In vitro analysis of photosensitizer accumulation for assessment of applicability of fluorescence diagnosis of squamous cell carcinoma of epidermolysis bullosa patients. 2013 Biomed Res Int pmid:23509735
Ziegler V et al. Photosensitizer adhered to cell culture microplates induces phototoxicity in carcinoma cells. 2013 Biomed Res Int pmid:23509741
Kashef N et al. Photodynamic effect of hypericin on the microorganisms and primary human fibroblasts. 2013 Photodiagnosis Photodyn Ther pmid:23769281
Cona MM et al. Comparative study of iodine-123-labeled hypericin and (99m)Tc-labeled hexakis [2-methoxy isobutyl isonitrile] in a rabbit model of myocardial infarction. 2013 J. Cardiovasc. Pharmacol. pmid:23714775
Verfaillie T et al. Pro-apoptotic signaling induced by photo-oxidative ER stress is amplified by Noxa, not Bim. 2013 Biochem. Biophys. Res. Commun. pmid:23916707
Mikešová L et al. Conjunction of glutathione level, NAD(P)H/FAD redox status and hypericin content as a potential factor affecting colon cancer cell resistance to photodynamic therapy with hypericin. 2013 Photodiagnosis Photodyn Ther pmid:24284100
Noell S et al. Microendoscopy for hypericin fluorescence tumor diagnosis in a subcutaneous glioma mouse model. 2013 Photodiagnosis Photodyn Ther pmid:24284111
Penjweini R et al. Optimizing the antitumor selectivity of PVP-Hypericin re A549 cancer cells and HLF normal cells through pulsed blue light. 2013 Photodiagnosis Photodyn Ther pmid:24284116
de Melo Wde C et al. Electroporation enhances antimicrobial photodynamic therapy mediated by the hydrophobic photosensitizer, hypericin. 2013 Photodiagnosis Photodyn Ther pmid:24284122
Dror N et al. Unique anti-glioblastoma activities of hypericin are at the crossroad of biochemical and epigenetic events and culminate in tumor cell differentiation. 2013 PLoS ONE pmid:24066060
Righeschi C et al. Microarray-based mRNA expression profiling of leukemia cells treated with the flavonoid, casticin. 2012 May-Jun Cancer Genomics Proteomics pmid:22593249
Yow CM et al. Hypericin-mediated photodynamic antimicrobial effect on clinically isolated pathogens. 2012 May-Jun Photochem. Photobiol. pmid:22233203
Rezusta A et al. In vitro fungicidal photodynamic effect of hypericin on Candida species. 2012 May-Jun Photochem. Photobiol. pmid:22128758
Youssef T et al. Evaluation of hypericin-loaded solid lipid nanoparticles: physicochemical properties, photostability and phototoxicity. 2012 Mar-Apr Pharm Dev Technol pmid:21047275
Dai T et al. Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. 2012 Front Microbiol pmid:22514547
Li JY et al. Management of cutaneous T cell lymphoma: new and emerging targets and treatment options. 2012 Cancer Manag Res pmid:22457602
Olivo M et al. Altered expression of cell adhesion molecules leads to differential uptake of hypericin in urothelial cancer. 2012 Urol. Oncol. pmid:20933443
Fasinu PS et al. An overview of the evidence and mechanisms of herb-drug interactions. 2012 Front Pharmacol pmid:22557968
López-Chicón P et al. On the mechanism of Candida spp. photoinactivation by hypericin. 2012 Photochem. Photobiol. Sci. pmid:22566080
Sharma KV and Davids LM Depigmentation in melanomas increases the efficacy of hypericin-mediated photodynamic-induced cell death. 2012 Photodiagnosis Photodyn Ther pmid:22594986
Penjweini R et al. Long-term monitoring of live cell proliferation in presence of PVP-Hypericin: a new strategy using ms pulses of LED and the fluorescent dye CFSE. 2012 J Microsc pmid:21974829
Mortensen T et al. Investigating the effectiveness of St John's wort herb as an antimicrobial agent against mycobacteria. 2012 Phytother Res pmid:22294548
Nakajima N and Kawashima N A basic study on hypericin-PDT in vitro. 2012 Photodiagnosis Photodyn Ther pmid:22959799
Marysael T et al. Pretargeting of necrotic tumors with biotinylated hypericin using 123I-labeled avidin: evaluation of a two-step strategy. 2012 Invest New Drugs pmid:22187204
Garg AD et al. Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. 2012 Cancer Immunol. Immunother. pmid:22193987
Krammer B and Verwanger T Molecular response to hypericin-induced photodamage. 2012 Curr. Med. Chem. pmid:22214453
Dalmizrak O et al. Evaluation of the in vitro inhibitory impact of hypericin on placental glutathione S-transferase pi. 2012 Protein J. pmid:22810152
Shi YW et al. [Rapid cloning and functional characterization of hypericin synthase gene]. 2012 Yao Xue Xue Bao pmid:22812015
Huntosova V et al. Development of a new LDL-based transport system for hydrophobic/amphiphilic drug delivery to cancer cells. 2012 Int J Pharm pmid:22814227
Cencic R et al. Inhibitors of translation targeting eukaryotic translation initiation factor 4A. 2012 Meth. Enzymol. pmid:22713332
Ritz R et al. In vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells. 2012 PLoS ONE pmid:23251668
Besic Gyenge E et al. Effects of hypericin and a chlorin based photosensitizer alone or in combination in squamous cell carcinoma cells in the dark. 2012 Photodiagnosis Photodyn Ther pmid:23200013
Valeri A et al. Effects of St John's wort and its active constituents, hypericin and hyperforin, on isolated rat urinary bladder. 2012 J. Pharm. Pharmacol. pmid:23146040
Šemeláková M et al. The pro-apoptotic and anti-invasive effects of hypericin-mediated photodynamic therapy are enhanced by hyperforin or aristoforin in HT-29 colon adenocarcinoma cells. 2012 J. Photochem. Photobiol. B, Biol. pmid:23099482
Sharma KV and Davids LM Hypericin-PDT-induced rapid necrotic death in human squamous cell carcinoma cultures after multiple treatment. 2012 Cell Biol. Int. pmid:23005701
Olivo M et al. New frontier in hypericin-mediated diagnosis of cancer with current optical technologies. 2012 Ann Biomed Eng pmid:22124793
Li JJ et al. A single-dose toxicity study on non-radioactive iodinated hypericin for a targeted anticancer therapy in mice. 2012 Acta Pharmacol. Sin. pmid:23103619
He M et al. De novo sequencing of Hypericum perforatum transcriptome to identify potential genes involved in the biosynthesis of active metabolites. 2012 PLoS ONE pmid:22860059
Spindler SR et al. Novel protein kinase signaling systems regulating lifespan identified by small molecule library screening using Drosophila. 2012 PLoS ONE pmid:22363408